Table 3.
Mycotoxin risk assessment through medicinal herbs dietary supplement tablets consumption
| Sample | Medium recommended dosage (g) | ZEA | OTA | ||||
|---|---|---|---|---|---|---|---|
| Concentration µg/g | EDI µg/kg bw/day | %TDI | Concentration µg/g | EDI µg/kg bw/day | %TDI | ||
| Boldus | 1.83 | LBa | |||||
| 1.135 | 0.0297 | 11.87 | nd | nd | nd | ||
| UBb | |||||||
| 1.138 | 0.0297 | 11.89 | nd | nd | nd | ||
| Ginger | 1.49 | LB | |||||
| 0.962 | 0.0205 | 8.19 | nd | nd | nd | ||
| UB | |||||||
| 0.97 | 0.0206 | 8.26 | nd | nd | nd | ||
| Devil’s clawroot | 1.16 | LB | |||||
| 0.053 | 0.0009 | 0.35 | nd | nd | nd | ||
| LB | |||||||
| 0.061 | 0.001 | 0.4 | nd | nd | nd | ||
| Lemon balm | 0.93 | LB | |||||
| 0.039 | 0.0005 | 0.21 | nd | nd | nd | ||
| UB | |||||||
| 0.0 .00.046 | 0.046 | 0.0006 | 0.24 | N nd | nd nd | ||
| Fucus | 1.3 | LB | |||||
| 0.131 | 0.0024 | 0.98 | nd | nd nd | |||
| UB | |||||||
| 0.0 .00.046 | 0.139 | 0.0026 | 1.04 | nd | nd nd | ||
| Herbal mixed for treat insomnia | 0.85 | LB | |||||
| nd | nd | nd | 0.05 | 0.0006 | 3.57 | ||
| UB | |||||||
| nd | nd | nd | 0.05 | 0.0006 | 3.92 | ||
TDI ZEA (0.25 μg/kgbw/day) (EFSA, 2014); TWI OTA (0.12 µg/kg bw/week) (EFSA, 2006)
aLB (lower bound);bUB (upper bound)